HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Acepromazine

HCID 6077
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
61-00-7
Standard SMILES
CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2
InChIKey
NOSIYYJFMPDDSA-UHFFFAOYSA-N
Molecular formula
C19H22N2OS
Average molar mass
326.5 g/mol
Monoisotopic mass
326.1452845

Overview

Acepromazine is a member of the class of phenothiazines that is 10H-phenothiazine substituted by an acetyl group at position 2 and a 3-(dimethylamino)propyl group at position 10. It has a role as a phenothiazine antipsychotic drug. It is a member of phenothiazines, a tertiary amino compound, a methyl ketone and an aromatic ketone.

Names & identifiers

Preferred name
Acepromazine
IUPAC
1-[10-[3-(dimethylamino)propyl]phenothiazin-2-yl]ethanone
English name
acepromazine
Molecular formula
C19H22N2OS
Molecular weight
326.46

Names & synonyms

ACEPROMAZINEAcetylpromazineAcetopromazine61-00-7AcepromazinaAtravetAcezine 2Acepromazinum10-(3-Dimethylaminopropyl)phenothiazin-3-yl methyl ketoneConcentrat vo3410-(3-Dimethylaminopropyl)phenothiazine-3-ethyloneEthanone, 1-(10-(3-(dimethylamino)propyl)-10H-phenothiazin-2-yl)-
Show more names
1522CBA 23051NotensilVetranquilAids013600Aids-013600Acetylperazine
54EJ303F0R1-(10-(3-(Dimethylamino)propyl)-10H-phenothiazin-2-yl)ethanoneEthanone, 1-[10-[3-(dimethylamino)propyl]-10H-phenothiazin-2-yl]-1-[10-(3-DIMETHYLAMINO-PROPYL)-10H-PHENOTHIAZIN-2-YL]-ETHANONEDTXSID1022552CHEBI:449321-{10-[3-(dimethylamino)propyl]-10H-phenothiazin-2-yl}ethanone1-{10-[3-(dimethylamino)propyl]-10H-phenothiazin-2-yl}ethan-1-one

Database identifiers

CAS
61-00-7
PubChem CID
6077
DTXSID
DTXSID1022552

Properties

Computed structural propertiesFilling in

XLogP
4.2
Topological polar surface area
48.9 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
4
Rotatable bonds
5
Heavy atoms
23
Formal charge
0
Complexity
414

Experimental & physicochemical properties

Drugs · 2 items

DEA NFLIS-Drug Category -> Depressants and Tranquilizers

Pharmaceuticals -> Listed in ZINC15

Solubility9.80e-03 g/L
Animal Drugs · 2 items

Pharmaceuticals -> UK Veterinary Medicines Directorate List

Pharmaceuticals -> Animal Drugs -> Approved in Taiwan

Melting Point · 2 items

< 25 °C

< 25 °C

Physical DescriptionSolid
Collision Cross Section · 4 items

176.6 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]

169.77 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

160.5 Ų [M+H]+ [CCS Type: TW]

186.38 Ų [M+Na]+

Physicochemical properties

Melting point
25 °C · <25 °C

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

P261, P262, P264, P264+P265, P270, P271, P272, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P316, P319, P321, P330, P332+P317, P333+P317, P337+P317, P361+P364, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 38 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory Information · 2 items

REACH registered substance: Acepromazine (EC: 200-496-0)

Ethanone, 1-10-3-(dimethylamino)propyl-10H-phenothiazin-2-yl-: Does not have an individual approval but may be used under an appropriate group standard

Hazard Classes and CategoriesAcute Tox. 3 (100%)

Safety data

Toxicity
LD50 intraperitoneal in mouse: 350mg/kg
Signal word
Danger
Symbol(GHS)
GHS06
Hazard statements
H319-H317-H311-H335-H315-H331-H301
REACH Registrations
Active
Precautionary statements
P264-P280-P302+P352-P321-P332+P313-P362-P261-P272-P280-P302+P352-P333+P313-P321-P363-P501-P264-P280-P305+P351+P338-P337+P313P-P280-P302+P352-P312-P322-P361-P363-P405-P501-P261-P271-P304+P340-P311-P321-P403+P233-P405-P501-P264-P270-P301+P310-P321-P330-P405-P501

Chemistry & industry

Pharmacology

ATC Code · 2 items

N - Nervous system

QN - Nervous system

Pharmacodynamics · 1 item

Acepromazine is one of the phenothiazine derivative psychotropic drugs. Acepromazine has actions at all levels of the central nervous system-primarily at subcortical levels-as well as on multiple organ systems. Acepromazine has strong antiadrenergic and weaker peripheral anticholinergic activity; ganglionic blocking action is relatively slight. It also possesses slight antihistaminic and antiserotonin activity.

Mechanism of Action · 1 item

Acepromazine acts as an antagonist (blocking agent) on different postsysnaptic receptors -on dopaminergic-receptors (subtypes D1, D2, D3 and D4 - different antipsychotic properties on productive and unproductive symptoms), on serotonergic-receptors (5-HT1 and 5-HT2, with anxiolytic, antidepressive and antiaggressive properties as well as an attenuation of extrapypramidal side-effects, but also leading to weight gain, fall in blood pressure, sedation and ejaculation difficulties), on histaminergic-receptors (H1-receptors, sedation, antiemesis, vertigo, fall in blood pressure and weight gain), alpha1/alpha2-receptors (antisympathomimetic properties, lowering of blood pressure, reflex tachycardia, vertigo, sedation, hypersalivation and incontinence as well as sexual dysfunction, but may also attenuate pseudoparkinsonism - controversial) and finally on muscarinic (cholinergic) M1/M2-receptors (causing anticholinergic symptoms like dry mouth, blurred vision, obstipation, difficulty/inability to urinate, sinus tachycardia, ECG-changes and loss of memory, but the anticholinergic action may attenuate extrapyramidal side-effects).

Biological Half-Life3 hours in horses.
MeSH Pharmacological Classification · 2 items

Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus.

Related reactions

1 records
New reaction record
HRID 1078539 reaction equation
HRID 1078539As reactant

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
ChEMBL
CHEMBL39560
ChEBI
CHEBI:44932
UNII
54EJ303F0R
EC Number
200-496-0
Nikkaji
J4.812G
Boiling point
0.5 · bp0.5 220-240°
Density
1.1075 · 1.1075 (rough estimate)
refractive index
1.595 · 1.5950 (estimate)
pka
9.41 · 9.41±0.28(Predicted)
color
Orange oil
Water Solubility
16 mg/L · 16mg/L(25 ºC)
FDA UNII
54 EJ303F0R · 54EJ303F0R
ATC code
5 AA04 · N05AA04
Symbol(GHS)
6 · GHS06
Signal word
Danger
Hazard statements
319 · H319-H317-H311-H335-H315-H331-H301
Precautionary statements
264 · P264-P280-P302+P352-P321-P332+P313-P362-P261-P272-P280-P302+P352-P333+P313-P321-P363-P501-P264-P280-P305+P351+P338-P337+P313P-P280-P302+P352-P312-P322-P361-P363-P405-P501-P261-P271-P304+P340-P311-P321-P403+P233-P405-P501-P264-P270-P301+P310-P321-P330-P405-P501
Toxicity
50 intraperitoneal · LD50 intraperitoneal in mouse: 350mg/kg
REACH Registrations
Active

Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME.

Cellular LocationsExtracellular

Uses & manufacturing

Use ClassificationPharmaceuticals -> Animal Drugs -> Approved in Taiwan

Applications

UsesSedative (veterinary).

Upstream & downstream products

Upstream raw materials

1-(2-acetylphenothiazin-10-yl)ethanone1-[10-(3-chloropropyl)-10H-phenothiazin-2-yl]ethan-1-onemethyl phenothiazin-10-yl ketoneDimethylamine3-Chloro-1-(N,N-dimethyl)propylamine2-Acetylphenothiazine2-BromothiophenolPhenothiazine
Additional notes · 1 item

DefinitionChEBI: Acepromazine is a member of the class of phenothiazines that is 10H-phenothiazine substituted by an acetyl group at position 2 and a 3-(dimethylamino)propyl group at position 10. It has a role as a phenothiazine antipsychotic drug. It is a methyl ketone, an aromatic ketone, a tertiary amino compound and a member of phenothiazines.